Advanced Search

 

Study ID Status Title Patient Level Data
FMS30054 Completed A Multicentre, Randomised, Double-Blind, Parallel-Group Study to Compare the Safety and Efficacy of Fluticasone Propionate 750µg bd (1500µg/Day) with that of Beclomethasone Dipropionate 750µg bd (1500µg/Day) in Geriatric Patients with Chronic Asthma
FMS30055 Completed A Multicentre, Randomised, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 1mg bd (2mg Daily) Administered by Pressurised Inhaler with that of Fluticasone Propionate 1mg bd (2mg Daily) Administered as a Dry Powder Via a Diskhaler Inhaler and an Ope ...
FMS30058 Completed A multicenter, randomized, double-blind, parallel group, placebo-controlled, 12 week study of Fluticasone Propionate 44mcg BID and 88mcg BID delivered via CFC MDI and a valved holding chamber with facemask in subjects with asthma age 24 months to 47 months Study Listed on ClinicalStudyDataRequest.com
FMS30059 Completed A multicenter, randomized, double-blind, parallel group, placebo-controlled, 12 week study of Fluticasone Propionate 44mcg BID and 88mcg BID delivered via CFC MDI and a valved holding chamber with facemask in subjects with asthma age 6 months to 2 years Study Listed on ClinicalStudyDataRequest.com
FMS30060 Completed Anti-inflammatory treatment of infants with persistent dyspnoea (Early Wheezing).
FMS40001 Completed A randomised, double-blind, double-dummy, parallel group, multicentre study to compare the effect on growth measured by stadiometry of fluticasone propionate (100µg bd) administered via DISKUS™ with budesonide (200µg bd) administered via Turbuhaler in prepubescent children. Study Listed on ClinicalStudyDataRequest.com
FMS40010 Completed Comparing the efficacy of the antileukotriene montelukast to fluticasone 200µg in steroid naïve subjects with mild to moderate asthma.
FMS40012 Completed Evaluation of the potential anti-inflammatory action of Leukotriene D4 receptor antagonists: comparison of Zafirlukast, an LDT4 receptor antagonist with low-dose fluticasone propionate, an inhaled steroid on sputum eosinophils in mild asthma
FMS40038 Completed A randomized, double-blind, placebo-controlled, parallel-group study to assess the equivalence of fluticasone propionate 100mcg BID via MDI, formulated with 1% and 10% lecithin
FMS40049 Completed Multi-centre, randomised, double-blind, parallel-group study to determine the clinical equivalence between fluticasone propionate 500?g once daily and fluticasone propionate 250?g twice daily, both delivered via the metered-dose-inhaler (MDI) in patients with moderate asthma.
FMS40121 Completed A double blind, parallel group, two way study to compare a high starting dose of fluticasone (1000 µg/day) tapering off to a low maintenance dose (100 µg/day) and a continuous intermediate dose (200 µg/day) in asthmatic children aged 6 to 10 years.
FMS40137 Completed A Randomized, Double-Blind, Parallel-Group, Comparative Trial Assessing the Long Term Safety of Inhaled Fluticasone Propionate Rotadisks Via Diskhaler 50mcg BID and 100mcg BID Versus Placebo in Patients Aged 4 to 11 Years with Mild to Moderate Chronic Asthma
FMS40163 Completed Effect of fourteen weeks treatment with fluticasone propionate step-down dosing from 1000mcg/day in comparison with a fixed dose of 200mcg/day followed by an open phase with placebo administered for 8 weeks in subjects with mild asthma who exacerbate during treatment with beta-2 agonist (prn).
FMS40166 Completed A general practice, single-centre, randomised, double-blind, placebo controlled parallel group study to determine the effect of 2 weeks treatment with fluticasone propionate 2 x 250 mcg bd MDI via Volumatic spacer in patients with persistent cough and/or acute bronchitis.
FMS40175 Completed Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
FMS40180 Completed A placebo controlled trial studying the effect of a single dose inhaled fluticasone propionate on the bronchial diameter and the severity of exercise-induced asthma.Extensive searching has revealed that no clinical report is available for this study.
FMS40185 Completed A comparative study of the effects of fluticasone propionate (FP) and beclomethasone dipropionate (BDP) on non-specific bronchial hyperresponsiveness.Extensive searching has revealed that no clinical study report is available for this study.
FMS40190 Completed A Multicentre, Four-Week, Double-Blind, Parallel-Group Comparison of Fluticasone Propionate (50?g, 100?g, 200?g, and 400?g bd) with Beclomethasone Dipropionate (200?g bd) in Patients with Moderately Severe Asthma
FMS40201 Completed A single-centre, double-blind, cross-over study to investigate adrenal function in asthmatic children receiving treatment with inhaled beclomethasone dipropionate, 400?g/M2 or more daily, compared to half the dose of fluticasone propionate.
FMS40224 Completed A multicenter, randomized, double-blind, placebo controlled study to compare the efficacy and safety of fluticasone propionate dry powder 200mcg daily via a Diskhaler inhaler and fluticasone propionate 100mcg daily via a Diskhaler inhaler in comparison with placebo dry powder via a Diskhaler inh ...
FMS40229 Completed Efficacy of treatment with inhaled fluticasone and the effect of priming and activation of PMN cells in children with allergy and asthma.Extensive searching has revealed that no clinical report is available for this study.
FMS40230 Completed A multicentre, randomised, double-blind, parallel group, 12 month study to compare the safety and tolerability of fluticasone propionate 500mcg twice daily with beclomethasone dipropionate 1000mcg twice daily administered via the pressurised inhaler in adults with severe chronic asthma
FMS40232 Completed A single-centre, double-blind study to investigate the effects of inhaled fluticasone propionate (FP) 1500mcgdaily on inflammatory processes in the lungs of patients with chronic obstructive airways disease.
FMS40240 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group, six-week study to compare the efficacy and safety of fluticasone propionate 1000µg and 2000µg daily with budesonide 1600µg daily, all via pressurised inhaler, in patients with severe chronic asthma.
FMS40243 Completed A Comparison of the Pharmacokinetics and Pharmacodynamics of Inhaled Fluticasone Propionate in Healthy Volunteers and Subjects with Chronic Obstructive Pulmonary Disease

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.